International Journal of Cancer · 2009 · 55 citations · 38 references
MedicineOncologyPharmacologyApoptosisChemotherapyMolecular OncologyApoptosis In CancerApoptosis RegulationApoptosis ResistanceApoptotic SignalingCytotoxic ChemotherapyProstate CancerApoptosis Regulation By KinasesApoptosis Signaling In CancerChemotherapy For Prostate CancerEnzyme ActivityEnzyme Activity RegulationHormone-induced Apoptosis ResistanceSphingosine 1-Phosphate SignalingSphingosine-1-phosphate Signaling
It has recently been shown that docetaxel chemotherapy is effective in prolonging life in patients with prostate cancer (PCa). We have investigated potential ways of increasing the effectiveness of chemotherapy in this disease. We have previously reported that sphingosine kinase 1 (SphK1) inhibition is a key step in docetaxel-induced apoptosis in the PC-3 PCa cell line and that pharmacologicalSphK1 inhibition is chemosensitizing in the docetaxel-resistant PCa LNCaP cell line. In this study we have addressed the mechanism of docetaxel-induced apoptosis of PC-3 cells and identified SphK1-dependent and -independent components. We have shown that SphK1 inhibition by docetaxel is a two-step process involving an initial loss of enzyme activity followed by a decrease in SphK1 gene expression. Using hormoneresistant PC-3 and DU145 PCa cells we have demonstrated that both pharmacological and siRNA-mediated SphK1 inhibition leads to a four-fold decrease in the docetaxel IC50 dose. This work points out to potential ways of increasing the effectiveness of chemotherapy for PCa by SphK1 inhibition.
38
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Olivier Cuvillier, Grisha Pirianov, Burkhard Kleuser et al. · Nature · 1996 · 1.5K citations
Discovery and evaluation of inhibitors of human sphingosine kinase.
Kevin J. French, Randy S. Schrecengost, Brian D. Lee et al. · PubMed · 2003 · 600 citations
Medicine, Oncology, Pharmacology +10
Bcl2 is the guardian of microtubule integrity.
Swati Haldar, Aruna Basu, Carlo M. Croce · PubMed · 1997 · 599 citations
Medicine, Oncology, Pharmacology +17